Heart Tronics Stock

Heart Tronics AAQS

The The AAQS of Heart Tronics (HRTT) as of Aug 6, 2026 is 2.

AAQS

2

Last updated:

Heart Tronics has a current AAQS of 2.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Heart Tronics in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
Access this data via the Eulerpool API

Heart Tronics Stock analysis

What does Heart Tronics do? Heart Tronics Inc. is a company specializing in the development of medical devices and technologies aimed at monitoring and treating heart diseases. It was founded in 2000 by Dr. A. Martin Gerdes and is headquartered in Irvine, California. The company's business model is based on the development, production, and sale of life-saving medical devices. They offer a wide range of diagnostic and monitoring devices that help doctors diagnose and treat heart diseases. One of their main focuses is the development of devices for monitoring heart rhythm disorders, including factors like blood pressure, pulse rate, and respiratory rate. They also develop devices for the treatment of heart diseases, such as electrophysiological (EP) ablation devices and implantable cardioverter-defibrillators (ICD). Additionally, they have developed telemedicine products for remote patient monitoring, allowing doctors to monitor and analyze patient data in real time. Overall, Heart Tronics has developed a variety of products that have proven effective in the medical community and are focused on saving lives by helping doctors detect diseases and take preventive measures. The company is well positioned for future growth due to advancements in telemedicine and medical devices. They plan to expand their portfolio to develop even more life-saving technologies in the future. In conclusion, Heart Tronics is a company driven by the clear goal of saving lives. They have established themselves as pioneers in the development of medical devices for the treatment of heart diseases and are committed to continuously developing innovative technologies to improve people's lives. Heart Tronics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Heart Tronics stock

The AAQS of Heart Tronics is 2 in 2026.

On Eulerpool you can find the complete historical development of The AAQS Heart Tronics since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

Quality — Heart Tronics

All Key Metrics — Heart Tronics